Top 5 Stock Picks of Eli Casdin’s Casdin Capital

Page 5 of 5

1. BioLife Solutions, Inc. (NASDAQ:BLFS)

Casdin Capital’s Stake Value: $171,982,000
Percentage of Casdin Capital’s Portfolio: 7.71%
Number of Hedge Fund Holders: 12

BioLife Solutions, Inc. (NASDAQ:BLFS), which develops, produces, and provides bio-production technology and services in the United States, Africa, Canada, Europe, the Middle East, and internationally, serves the cell and gene therapy industry. Eli Casdin’s Casdin Capital is one of the leading shareholders of BioLife Solutions, Inc. (NASDAQ:BLFS), with 7.57 million shares worth about $171.98 million. BioLife Solutions, Inc. (NASDAQ:BLFS) accounted for 7.71% of the hedge fund’s portfolio.BioLife Solutions, Inc. (NASDAQ:BLFS) is the most significant investment in Casdin Capital’s portfolio.

Maxim analyst Jason McCarthy maintained a ‘Buy’ rating on BioLife Solutions, Inc. (NASDAQ:BLFS) on May 12 while reducing his price target to $30 from $60. Though the company reported another solid quarter, the analyst cautioned investors in a research note that market challenges brought on by rising interest rates and inflation reduced the stock’s multiple.

Overall, hedge funds are loading up on BioLife Solutions, Inc. (NASDAQ:BLFS). Among the hedge funds tracked by Insider Monkey, 12 funds were long BioLife Solutions, Inc. (NASDAQ:BLFS) in the March quarter, down from 15 funds in the preceding quarter.

In its Q3 2020 Investor Letter, Wasatch Advisors mentioned BioLife Solutions, Inc. (NASDAQ: BLFS) and discussed its stance on the firm. Here is what the fund said:

 “A significant purchase during the quarter was BioLife Solutions, Inc. (BLFS). BioLife Solutions was not only one of our newer holdings, it was also a strong performer for the quarter. The company provides proprietary biopreservation products used in cell therapy, gene therapy and regenerative medicine. BioLife’s flagship product, CryoStor,® has garnered increased attention from investors because of its potential use in coronavirus vaccines requiring storage at very cold temperatures. In addition, the company offers thawing products, a cold-chain transport system and high-capacity freezers—all of which also have applications to the prospective distribution programs of certain vaccine candidates for Covid-19.”

You can also take a peek at Top 10 Stock Picks of Teresa Barger’s Cartica Management and Top 10 Stock Picks of Cannell Capital.

Page 5 of 5